Literature DB >> 28495525

Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.

Philip A LoBue1, Jonathan H Mermin2.   

Abstract

Since 1989, the USA has been pursuing the goal of tuberculosis elimination. After substantial progress during the past two decades, the rate of tuberculosis cases in the USA each year has now levelled off and remains well above the elimination threshold. Both epidemiological data and modelling underline the necessity of addressing latent tuberculosis infection if further progress is to be made in eliminating the disease. In this Personal View we explore next steps towards elimination. Given the estimated prevalence of latent tuberculosis infection, compared with the limited testing and treatment that currently occur, a major new effort is required. This effort should consist of a surveillance system or registry to monitor progress, scale-up of targeted testing for latent tuberculosis infection in at-risk populations, scale-up of short-course treatment regimens, engagement of affected communities and medical providers who serve those communities, and increased public health staffing for implementation and oversight. Such an effort would benefit greatly from the development of new tools, such as tests that better indicate reactivation risk, and even shorter latent tuberculosis infection treatment regimens than currently exist.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28495525      PMCID: PMC5614812          DOI: 10.1016/S1473-3099(17)30248-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  38 in total

1.  Determining TB rates and TB case burden for refugees.

Authors:  D S Hadzibegovic; S A Maloney; S T Cookson; A Oladele
Journal:  Int J Tuberc Lung Dis       Date:  2005-04       Impact factor: 2.373

2.  Nucleic acid amplification tests for tuberculosis.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1996-11-01       Impact factor: 17.586

3.  Incentives vs outreach workers for latent tuberculosis treatment in drug users.

Authors:  C K Malotte; J R Hollingshead; M Larro
Journal:  Am J Prev Med       Date:  2001-02       Impact factor: 5.043

4.  A field-validated approach using surveillance and genotyping data to estimate tuberculosis attributable to recent transmission in the United States.

Authors:  Anne Marie France; Juliana Grant; J Steve Kammerer; Thomas R Navin
Journal:  Am J Epidemiol       Date:  2015-10-13       Impact factor: 4.897

5.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

6.  Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention.

Authors:  Gerald H Mazurek; Margarita E Villarino
Journal:  MMWR Recomm Rep       Date:  2003-01-31

7.  Challenges and opportunities in a tuberculosis outbreak investigation in southern Mississippi, 2005-2007.

Authors:  Emily Bloss; Kimberly Newbill; Heather Peto; Michael J Rice; Gail Ainsworth; Robert Travnicek; Mike Holcombe; Maryam B Haddad; John E Oeltmann
Journal:  South Med J       Date:  2011-11       Impact factor: 0.954

8.  Delayed tuberculosis diagnosis and tuberculosis transmission.

Authors:  J E Golub; S Bur; W A Cronin; S Gange; N Baruch; G W Comstock; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2006-01       Impact factor: 2.373

Review 9.  A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries.

Authors:  Lorenzo Zammarchi; Gianluigi Casadei; Marianne Strohmeyer; Filippo Bartalesi; Carola Liendo; Alberto Matteelli; Maurizio Bonati; Eduardo Gotuzzo; Alessandro Bartoloni
Journal:  BMC Health Serv Res       Date:  2015-09-24       Impact factor: 2.655

10.  Characteristics of tuberculosis cases that started outbreaks in the United States, 2002-2011.

Authors:  Maryam B Haddad; Kiren Mitruka; John E Oeltmann; Emma B Johns; Thomas R Navin
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

View more
  37 in total

1.  Not So Fast: Slowing Tuberculosis Decline in California.

Authors:  Julie Higashi; Pennan Barry
Journal:  Am J Public Health       Date:  2019-02       Impact factor: 9.308

2.  Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection.

Authors:  Thara K Venkatappa; Rose Punnoose; Dolly J Katz; Michael P Higgins; Niaz Banaei; Edward A Graviss; Robert W Belknap; Christine S Ho
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

3.  Using Reports of Latent Tuberculosis Infection Among Young Children to Identify Tuberculosis Transmission in New York City, 2006-2012.

Authors:  Jennifer Sanderson Slutsker; Lisa Trieu; Aldo Crossa; Shama Desai Ahuja
Journal:  Am J Epidemiol       Date:  2018-06-01       Impact factor: 4.897

4.  Cancer Progress and Priorities: Lung Cancer.

Authors:  Matthew B Schabath; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

Review 5.  Epidemiology of Tuberculosis in the United States.

Authors:  Adam J Langer; Thomas R Navin; Carla A Winston; Philip LoBue
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 2.878

6.  QuantiFERON-TB Gold Versus Tuberculin Screening and Care Retention Among Persons Experiencing Homelessness: Georgia, 2015-2017.

Authors:  Jeffrey M Collins; Udodirim Onwubiko; David P Holland
Journal:  Am J Public Health       Date:  2019-05-16       Impact factor: 9.308

7.  Changes in tuberculosis epidemiology, United States, 1993-2017.

Authors:  L R Armstrong; C A Winston; B Stewart; C A Tsang; A J Langer; T R Navin
Journal:  Int J Tuberc Lung Dis       Date:  2019-07-01       Impact factor: 2.373

8.  Tuberculosis among Newly Arrived Immigrants and Refugees in the United States.

Authors:  Yecai Liu; Christina R Phares; Drew L Posey; Susan A Maloney; Kevin P Cain; Michelle S Weinberg; Kristine M Schmit; Nina Marano; Martin S Cetron
Journal:  Ann Am Thorac Soc       Date:  2020-11

Review 9.  The impact of migration on tuberculosis in the United States.

Authors:  N A Menzies; A N Hill; T Cohen; J A Salomon
Journal:  Int J Tuberc Lung Dis       Date:  2018-12-01       Impact factor: 2.373

10.  Number and cost of hospitalizations with principal and secondary diagnoses of tuberculosis, United States.

Authors:  M V Aslam; K Owusu-Edusei; S M Marks; G R B Asay; R Miramontes; M Kolasa; C A Winston; P M Dietz
Journal:  Int J Tuberc Lung Dis       Date:  2018-12-01       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.